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Abstract
Background: Family caregivers (FC) often experience higher distress levels than their relative with cancer. Many
cancer centers have implemented distress screening programs, but most of them concentrate their efforts on
patients, with little attention to their FC. To fill this gap, a pragmatic intervention has been designed to improve
supportive care for FC of patients with lung cancer. This article describes the study protocol of a single-center
randomized controlled trial to assess its effectiveness.
Methods/design: A total of 120 lung cancer patients and their FC are randomly assigned to the experimental
group (exposed to intervention, N = 60) or to the control group (usual care, N = 60). The intervention includes:
(1) systematic FC distress screening and problem assessment near their relative’s cancer diagnosis, and every
2 months, (2) privileged contact with an oncology nurse (ON) away from the patient to address FC problems
and (3) liaison by the ON with the family physician of FC reporting high distress (thermometer score ≥5/10), or
problems relying on FP expertise. In both groups, FC, patient and process-of-care outcomes are measured at
baseline and every 3 months, up to 9 months. The primary endpoint is FC distress measured by the Hospital
Anxiety and Depression Scale (HADS) and the Psychological Distress Index used in the Quebec Health Survey
(PDQHS). Individual interviews with 10 FC and a focus group with the oncology team will be conducted at the
study end to further document the effectiveness of the intervention and its impact on quality of life (for FC) and
practice organization (for the oncology team).
Discussion: This trial will assess the effectiveness of an innovative intervention based on interprofessional
collaboration between primary care and oncology care. It targets a population in great need, yet often
neglected, and has the potential to clearly improve patient and caregiver experience of cancer care, and
reduce the burden of disease.
Trial registration: ClinicalTrials.gov, ID: NCT02531464. Registered on 15 July 2015.
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Background
A diagnosis of cancer is emotionally threatening not
only for patients but also for their family caregivers (FC)
who witness and share much of the illness experience of
their relative [1]. Along the cancer care trajectory, FC
play a critical role in providing ongoing homecare and
assistance to their loved one [1]. However, they are often
unprepared to play their role and may experience gro-
wing levels of distress, as their relative’s condition dete-
riorates. Even though many FC are coping quite well,
studies show that 10 to 50% of them report high distress
[2, 3] which is often more severe than in patients [2, 4–7],
and it may persist over time, with a potential impact on
their physical, emotional and social health [1, 4, 8]. FC of
lung cancer patients are particularly vulnerable [7] and
likely to be distressed [9–13] because of a rapid evolution
[2, 8, 14] and decline in their relative’s functional
status associated with symptoms and treatment side
effects [1, 15–17].
FC may often feel unsupported in their role [18]
and would need more information and tips to fulfill it
[18]. Their unmet needs may compromise their qual-
ity of life (QoL) [19] and contribute to their distress
[20], but also they may adversely impact on their rel-
ative’s distress [21]. Because of the interrelation of the
patient-FC dyad experience, identifying and meeting
FC needs should be considered as an integral part of
cancer services [22–25]. It is recommended to assess
FC distress and needs early after diagnosis, and to re-
assess them regularly with cancer progression [26, 27]
in order to support them and help them play their
role in patient assistance and ongoing care through-
out the care trajectory. However, little is known on
the most effective interventions to develop and how
to implement them into routine practice [13, 27].
As recommended by many expert groups and health
authorities around the world [22–25], many cancer cen-
ters have implemented distress screening programs.
However, most of them concentrate their efforts mainly
on patients. In order to fill this gap, an intervention was
developed to improve supportive care for FC.
Development of the intervention
The multifaceted intervention was developed according
to the knowledge gained from the academic literature,
from previous research [28] and from recommendations
of expert groups and health authorities [22–25]. The
Screening for Distress tool currently used for cancer
patients in Quebec, Canada (including the Distress
Thermometer with the Canadian Problem Checklist and
the Edmonton Symptom Assessment Scale [29, 30]) was
adapted to the FC context (Fig. 1). Then, a pilot study
was conducted, consisting in individual interviews with
12 FC of patients at different phases of their lung cancer
(near diagnosis, during chemo/radiation therapy, after
the end of treatments), to get their comments and im-
pressions regarding this tool and the other components
of the intervention. FC also gave their opinion on the
most appropriate timing and frequency for completing
the Screening for Distress tool, and were invited to sug-
gest any other strategies that they would consider useful
to fulfill their needs. In addition, a focus group was con-
ducted with members of the IUCPQ oncology team and
their decision-makers, (where the intervention is tested),
to ensure its acceptability and feasibility in their practice.
IUCPQ is a tertiary care center in cardiology and pulmo-
nology in Quebec City (Quebec, Canada) where more
than 700 new patients with lung cancer are followed
each year. The oncology team (OT) is composed of pul-
monologists responsible for the treatment of these pa-
tients, oncology pivot nurses (OPN) who play a role of
resource person and cancer navigator for patients and
their family (each patient has a designated OPN to refer
to whenever needed), oncology nurses, social workers, a
psycho-oncologist, pharmacists and nutritionists. Finally,
a focus group with eight family physicians (FP) from dif-
ferent community-based practice settings (private clinics,
family medicine teaching units, community health cen-
ters) was conducted to ensure that the intervention was
also acceptable and feasible in their practice.
With the agreement of participants, individual inter-
views and focus group discussions were recorded to facili-
tate data collection. A content analysis of the recordings
was performed independently by a research professional
and one researcher to identify the modifications to the
intervention that were suggested by the different partici-
pants. They compared their notes and jointly pro-
duced a summary discussed with the research team
that served to adapt and refine the multifaceted inter-
vention accordingly.
Objectives
The main objective of this study is to implement and
assess the effectiveness of an intervention integrating
community-based primary care with oncology care to
improve supportive care for FC of lung cancer patients.
More specifically, this trial aims to assess the effective-
ness of the intervention on: (1) FC outcomes: distress
(primary outcome), anxiety, depression, quality of life
(QoL), needs, burden, perception of health, preparedness
in caregiving, social support, care satisfaction, (2) Patient
outcomes: distress, anxiety, depression, QoL, pain/other
symptom relief, (3) Care process outcomes: FC and patient
utilization of services. In addition, a qualitative component
of the study will further document, in the experimental
group, FC-perceived usefulness of the intervention and its
effects on distress/QoL, and in the oncology team, the
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Fig. 1 Distress Screening tool adapted to the family caregiver (FC) context
Aubin et al. Trials  (2017) 18:304 Page 3 of 10
perceived usefulness of the intervention and its effects on
their practice and organization of care.
Methods/design
A two arm-randomized controlled trial is conducted at a
single center, the IUCPQ Pulmonary Oncology Clinic, to
assess the effectiveness of the intervention (Fig. 2).
Description of the intervention
In the current practice at the IUCPQ Oncology Clinic,
there is a systematic distress screening program for pa-
tients, but not for FC. In their role towards patients and
their family throughout the cancer care trajectory, may
provide some support and information to FC and, in
rare occasions, refer them to appropriate resources.
However, most of their interventions target patients, and
only few FC receive support services. There is no sys-
tematic distress screening and problem assessment for
FC, nor any standardized service and resource specifi-
cally dedicated to them. The study intervention directly
targets FC of patients with lung cancer and aims to in-
crease the support provided to them. In order to prevent
contamination of the control group, an oncology nurse
(ON) with the training of an OPN [31, 32] has been re-
cruited specifically to administer the intervention to
FC randomly assigned to the experimental group. The
ON intervenes in addition to the usual care provided
by an OPN to patients and their family. The finalized
intervention includes three components and is summa-
rized in Fig. 2:
1. Systematic distress screening and needs/problems
assessment of family caregivers by the oncology nurse
FC from the experimental group complete the
adapted Screening for Distress tool early after the
diagnosis of their relative, and every 2 months
during the 9-month study. Whenever possible, they
complete this tool when they accompany their relative
at a regular visit to the clinic. Otherwise, arrangements
are made by the ON to either schedule a specific visit
for FC distress screening or mail them a copy of the
screening tool and complete it with them by phone.
The ON reviews the results of the Screening for
Distress tool
2. Privileged contact of the family caregiver with the
oncology nurse
The ON meets all FC away from their relative, after
their first completion of the distress screening and
needs/problems assessment tool. This professional
discusses with them results of this tool, and further
assesses their needs in order to plan with them
individualized problem-solving strategies, and, if
necessary, refers them to professional resources from
the IUCPQ Oncology Clinic or the community. The
training as an OPN provides the ON the basic skills
to support FC, acknowledging that it is normal for
them to go through different emotions (anxiety, fear,
sadness, helplessness, etc) in their situation, and
counsels them on the importance of taking care of
them and preserving time for them, while accom-
panying their relative. The ON provides community
resources and educational material (in addition to
what is usually given) related to their caregiving role,
and helps them to become better prepared and more
proactive in their role, also answering all remaining
questions asked by FC. Then, every 2 months, the
ON reviews FC results of the screening tool and
meets those who present a high level of distress
(thermometer score ≥5/10) or who
indicate needing help. The ON follows-up on prior
Fig. 2 The multi-faceted intervention
Aubin et al. Trials  (2017) 18:304 Page 4 of 10
strategies put in place to help FC and adjusts them
to the current situation. So the ON acts as a re-
source person for FC throughout the follow-up in
oncology
3. Liaison by the oncology nurse with the FC family
physician
For FC reporting high levels of distress
(thermometer score ≥5/10) or experiencing
problems relevant to FP expertise, the ON transfers
to their FP, information on their identified needs and
level of distress, and also provides to them
information on any strategy put in place or reference
to other health professionals to respond to FC
needs. The ON invites FP to give an appointment to
their patient, and facilitates a shared follow-up of the
FC when needed. If FC continue to present high levels
of distress or many needs/problems at subsequent
screenings, the ON transfers the information to their
FP and organizes another appointment/follow-up.
Most communications between the ON and FP
occur by fax, but they may also communicate by
phone if needed.
Study population
Patients diagnosed with a nonsurgical lung cancer (cor-
responding to more than 85% of all cases), having an
estimated life expectancy of at least 4 months (to mini-
mally ensure two data collections), and with FC iden-
tified by patients as their main caregiver, and who report
having a regular FP, are invited to participate to the study
by the OPN. FC are eligible independently of their health
status. Using a computer-generated randomization list,
these dyads are randomly assigned by the research team
to either the experimental group (exposed to the interven-
tion) or to the control group (usual care), as shown in
Fig. 3. As the study focuses mainly on FC, they can partici-
pate even if their relative with cancer decides not to par-
ticipate or withdraws before the end of the study. There is
no blinding in this trial, so participants and the research
team know the group allocation.
As FC distress is the primary outcome in this study,
the sample size was calculated from the mean scores of
distress found in a prior study conducted by our team
with a similar population of FC of patients with lung
cancer (unpublished abstract presented at the 16th
World Congress of Psycho-Oncology, Lisbon, Portugal,
23 October 2014). Based on FC distress scores of re-
spectively 13.7 ± 7.0 at the Hospital Anxiety Depression
Scale (HADS) (range = 0–42) and of 23 ± 16 at the
Psychological Distress Scale used in the Quebec
Health Survey (PDSQHS) (range = 0–100), a sample
size of 120 FC (60 per group) was calculated. Considering
a 5% α error, a power of 80% and an anticipated with-
drawal rate of 20% (due to patient deterioration or death),
this sample size allows to detect a 33% difference in dis-
tress scores between the two groups which is considered
clinically significant.
Procedures and data collection
At a regular visit of the patient who is most often ac-
companied by their FC, the OPN briefly explains the
study to them and asks permission to transfer their
phone number to the study team. Then, a research
professional contacts them to present the study more
extensively, get their agreement to participate and set
an appointment with them to sign the Consent Form
and begin the data collection with them. In both
groups, the research professional interviews separately
patients and FC at baseline and at 3-month intervals,
for a maximum of 9 months, or until the patient’s
death (maximum of four data collections), thus min-
imizing missing data (Fig. 3). Validated tools are used
to collect all the study outcomes. At baseline, FC re-
spond to basic questions related to their personal and
medical characteristics. They also complete the fol-
lowing validated questionnaires:
Primary outcomes:
Distress measured by two instruments: (1.1) the
HADS [33, 34], a 14-item instrument specifically
designed to evaluate distress, anxiety and depression.
For each item, the scale varies from 0 (most of the
time) to 3 (never). Using the standard criteria suggested
by authors of this instrument, distress scores are
converted into two categories (absence/presence of
distress) while anxiety and depression scores are
converted into three (absence/suspected/significant
anxiety or depression); (1.2) the global score of the
abbreviated version of the PDSQHS [35, 36]. This14-
item instrument was derived from the Psychiatric
Symptoms Index [37] and has been used in the Quebec
general population to estimate the prevalence of
clinically significant distress (scores ≥80th percentile),
so it permits the comparison of proportions of FC with
high distress levels to the ones found in the general
population. The PDSQHS scale varies from 1 (never) to
4 (very often).
Secondary outcomes:
Needs. The Home Caregiver Need Survey [38] is
a 25-item tool covering four categories of needs
(informational, practical, emotional and spiritual). FC
indicate, for each need, its perceived importance, on
a 0 (not important) to 4 (extremely important) scale,
and how well it is satisfied (0 = unsatisfied to 4 =
completely satisfied).
Psychological burden. The French version of the
Caregiver Burden Scale in End of Life Care (CBS-
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EOLC) [39] is a 16-item instrument validated among
FC who assist cancer patients in palliative phase.
Items vary from 1 (never) to 4 (very often).
Preparedness for caregiving. The Preparedness for
Caregiving Scale [40] measures the perceived
readiness for multiple domains of the caregiving role
(providing physical care, emotional support, setting
up in-home support services and dealing with the
stress of caregiving). This eight-item instrument
uses a 0 (not at all prepared) to 4 (very well
prepared) scale.
Quality of Life. The City of Hope-QoL Scale-Family
Version [41] is a 37-item instrument measuring four
QoL domains (physical, psychological, social and
spiritual), with questions using a 0–10 scale.
Service and health care resource utilization. FC
report the number of visits to their FP and to any
other health/psychosocial professional, meetings to
support groups, use of community resources
(volunteer services, respite, help for housework,
etc.), sick leave, and prescription of sleeping pills,
anxiolytic or antidepressant medications.
Measures are also taken at similar intervals with FC
relatives with lung cancer, since their physical and men-
tal health may influence FC. At baseline, patients re-
spond to basic questions related to their personal and
medical characteristics, and their functional status based
on the Karnofsky scale [42] which has a well-known cor-
respondence to the Eastern Collaborative Oncology
Group (ECOG) scale [43]. As for FC, they complete dis-
tress measures (PDSQHS and HADS) every 3 months, a
Healthnnrelated QoL measure (European Organization
for Research and Treatment of Cancer Quality of Life
Core 30: EORTC QLQ-C30) [44], and service and health
care resource utilization (frequency of emergency room
(ER) visits, hospitalizations, homecare services or other
services from the community health center). Figure 4
shows the schedule of enrollment, interventions and as-
sessments for all participants.
Fig. 3 Trial flow diagram
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To monitor the administration of the intervention,
additional information is collected with FC from the ex-
perimental group reporting high distress at screening:
the communication with FP, strategies put in place and
references to specific resources, as well as the number of
FC visits or phone contacts.
In order to promote participant retention, data collec-
tions are usually scheduled on the day of a patient regu-
lar visit to the oncology clinic. If no visit is planned at
the time of a data collection, the questionnaires are
mailed to the participants and they are contacted by
phone to determine the most convenient way to
complete them (either by themselves or with the re-
search professional who may go to their home or
complete the questionnaires with them over the phone).
Data from the questionnaires are coded in two sepa-
rate files and secured in a computer with a passcode.
The computer is located in a locked room accessed only
by the research team. A SPIRIT Checklist of all items
recommended in a randomized controlled trial is in-
cluded in Additional file 1.
Finally, individual interviews will be conducted with a
subgroup of FC in the experimental group at the end of
the study (N = 10 or until saturation) to document their
perception of the intervention usefulness and effect
on their QoL. Also, a focus group will be conducted
with the OPN and others professionals of the IUCPQ
OT, to assess their perception of the usefulness of the
intervention and its effect on their practice and
organization of care.
Analysis
The quantitative analysis plan first includes an eva-
luation of the adherence to the planned intervention by
verifying for each FC from the experimental group: (1)
the proportion of planned screening tools actually com-
pleted, (2) the proportion of liaisons with FP, (3) a de-
scriptive analysis of all interventions performed by the
ON (number of encounters, referrals, provision of edu-
cational material, etc.). Then, FC primary and secondary
outcomes will be compared between the experimental
and control groups at each data collection period. In
Fig. 4 Schedule of enrollment, interventions and assessments. FC: family caregiver, Pts: patients
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addition, mixed models for repeated measures will be
constructed with FC, patient and process-of-care out-
comes to assess the intervention effectiveness. These
analyses of variance for repeated measures will compare
the fluctuation over time of FC distress and other va-
riables between the experimental and control groups.
Whenever significant changes are found within one
group for certain outcomes over time, the mixed models
for repeated measures will help to identify when the
change occurred. Finally, McNemar tests will be used to
compare FC and patient distress.
The qualitative analysis will consist in content analysis
of the recordings of FC individual interviews and the
focus group with the OT, based on Miles and Huberman
methodology [45], to further document the perceived
usefulness of the intervention and its effect on FC QoL
and on the OT practice and organization of care. Each
interview will be independently analyzed by a research
professional and one researcher to ensure interobserver
reliability. In case of disagreement, perceptions will be
reviewed until a consensus is reached.
Discussion
FC play a crucial role in cancer patient care, represen-
ting their principal source of support [1]. However, they
often have their own lives put into upheaval [2, 8, 13, 14]
and neglect their health and needs to focus on supporting
their relative with cancer [4, 46]. It is well recommended
to provide FC with the resources, information and support
needed to maintain good health, and to sustain their care-
giving role [9, 27]. As emotional support appears to be an
important part of their role in cancer care [47, 48], FP
could be important actors in assessing FC health and ad-
vising them about resources to facilitate their caregiving
role [49]. The long-standing relationship with their pa-
tients and their usual familiarity with patient social con-
text put them in a strategic position to provide emotional
support. It is, thus, reasonable to assume that FP may
favorably influence FC distress when they accompany a
relative diagnosed with cancer.
Systematic screening for distress programs has been
implemented in many oncology centers, but their focus
has been limited to cancer patients, with little interven-
tion on FC. The intervention tested in this study aims
to address this gap by targeting more particularly FC, a
population in great need, yet often neglected. The inter-
vention has been pilot-tested to ensure its acceptability
for members of an oncology team working in a tertiary
care hospital and for community-based FP, and also to
confirm the appropriateness of the Screening for Dis-
tress tool, adapted to the FC context, as part of the
intervention. Preliminary consultation with the main
stakeholders involved is recognized as a fundamental
step prior to the implementation of any innovative
strategy. Without achieving such pilot work, there is a
risk of jeopardizing the implementation of the interven-
tion, thus reducing the possibility of finding any result
at the evaluative phase.
This randomized trial assesses the effectiveness of an
intervention using structures already in place to produce
practice changes and combining simple realistic strategies
of integrated care between primary care and oncology care
that transfer into practice the main recommendations of
expert groups and health authorities [22–25] to globally
improve cancer supportive care.
To prevent confounding bias from variable organization
of care, the study is restricted to a single center. However,
if the intervention is proven effective, its essential condi-
tions of success will be identified and could be replicated
in other settings and extended to other cancer sites. The
knowledge gained from the study findings may clearly
enhance QoL for cancer patients and their FC.
Trial status
Recruiting.
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